OTCMKTS:REPR - Repro-Med Systems Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.02
▲ +0.17 (5.96%)
1 month | 3 months | 12 months
Get New Repro-Med Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for REPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for REPR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Repro-Med Systems in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $3.02.
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Repro-Med Systems. This rating has held steady since May 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
6/20/2019Craig HallumInitiated CoverageBuy
i
(Data available from 4/21/2016 forward)
Repro-Med Systems logo
Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.
Read More

Today's Range

Now: $3.02
$2.80
$3.06

50 Day Range

MA: $3.65
$2.85
$4.01

52 Week Range

Now: $3.02
$1.35
$4.26

Volume

218,325 shs

Average Volume

36,047 shs

Market Capitalization

$120.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Repro-Med Systems?

The following equities research analysts have issued research reports on Repro-Med Systems in the last twelve months:
View the latest analyst ratings for REPR.

What is the current price target for Repro-Med Systems?

0 Wall Street analysts have set twelve-month price targets for Repro-Med Systems in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Repro-Med Systems in the next year.
View the latest price targets for REPR.

What is the current consensus analyst rating for Repro-Med Systems?

Repro-Med Systems currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for REPR.

What other companies compete with Repro-Med Systems?

How do I contact Repro-Med Systems' investor relations team?

Repro-Med Systems' physical mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company's listed phone number is 845-469-2042 and its investor relations email address is [email protected] The official website for Repro-Med Systems is www.rmsmedicalproducts.com.